GLPG Competitors & Alternatives
Compare Galapagos NV ADR with similar stocks in the same industry
Biotechnology
GLPG
Main Stock$27.73
Tradestie Score
46
Market Cap
$2.31B
P/E Ratio
5.1
Revenue Growth
10.9%
Analyst Upside
+3.0%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MESO
Mesoblast Limited American Depositary Shares
|
$17.00
|
$2.08B | - | 38 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$18.79
|
$2.02B | - | 26 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$12.84
|
$2.01B | - | 33 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$36.73
|
$1.97B | - | 55 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$11.08
|
$1.92B | - | 34 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$93.53
|
$1.92B | - | 46 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$68.62
|
$1.90B | 53.8 | 55 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$32.28
|
$1.84B | - | 57 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$36.88
|
$1.81B | - | 40 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.32
|
$1.78B | - | 40 | Compare |
More GLPG Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
241 stocks in this industry